In order to study the specific function of protein disulfide isomerase A3 precursor(PDIA3)in T cell receptor(TCR)signaling pathway, the PDIA3 protein level in T cells was knocked down by electroporation, the phosphorylation level of zeta-chain associated protein 70( ZAP70)protein was detected by enzyme linked immunosorbent assay(ELISA), and the expression level of cluster of differentiation 69(CD69)were analyzed by flow cytometry. The luciferase reporter gene detected NF-κB signaling pathway. The results showed that down-regulation of PDIA3 protein in T cells resulted in a significant decrease in ZAP70 protein phosphorylation, CD69 expression, IL-2 secretion, and affected NF-κB signaling pathway, indicating PDIA3 protein promotes the activation of T cells and participate in the regulation of T cell TCR signaling pathway. This work provides an important research basis for studying the interaction between PDIA3 and some functional proteins downstream of TCR in the future.
ZHOU Yun
,
LIU Hailong
,
JIN Zhaoyu
. PDIA3 regulates TCR signaling in human Jurkat T cells[J]. Journal of Hebei University(Natural Science Edition), 2020
, 40(3)
: 301
-306
.
DOI: 10.3969/j.issn.1000-1565.2020.03.011
[1] CHAKRABORTY A K, WEISS A. Insights into the initiation of TCR signaling[J]. Nature Immunology, 2014, 15(9): 798-807. DOI: 10.1038/ni.2940.
[2] COURTNEY A H, LO W L, WEISS A. TCR signaling: mechanisms of initiation and propagation[J]. Trends in Biochemical Sciences, 2018, 43(2): 108-123. DOI: 10.1016/j.tibs.2017.11.008.
[3] WEISS A, LITTMAN D R. Signal transduction by lymphocyte antigen receptors[J]. Cell, 1994, 76(2):263-274. DOI: 10.1016/0092-8674(94)90334-4.
[4] CHEN J X, DOROUDI M, CHEUNG J, et al. Plasma membrane Pdia3 and VDR interact to elicit rapid responses to 1α, 25(OH)2D3[J]. Cellular Signalling, 2013, 25(12): 2362-2373. DOI: 10.1016/j.cellsig.2013.07.020.
[5] EUFEMI M, COPPARI S, ALTIERI F, et al. ERp57 is present in STAT3-DNA complexes[J]. Biochemical and Biophysical Research Communications, 2004, 323(4): 1306-1312. DOI: 10.1016/j.bbrc.2004.09.009.
[6] GARBI N, TANAKA S, MOMBURG F, et al. Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57[J]. Nature Immunology, 2006, 7(1): 93-102. DOI: 10.1038/ni1288.
[7] GARBI N, HÄMMERLING G, TANAKA S. Interaction of ERp57 and tapasin in the generation of MHC class I-peptide complexes[J]. Current Opinion in Immunology, 2007,19(1): 99-105. DOI: 10.1016/j.coi.2006.11.013.
[8] HOLBROOK L M, SASIKUMAR P, STANLEY R G, et al. The platelet-surface thiol isomerase enzyme ERp57 modulates platelet function[J]. Journal of Thrombosis and Haemostasis, 2012, 10(2): 278-288. DOI: 10.1111/j.1538-7836.2011.04593.x.
[9] GRILLO C, DAMBROSIO C, SCALONI A, et al. Cooperative activity of Ref-1/APE and ERp57 in reductive activation of transcription factors[J]. Free Radical Biology and Medicine, 2006, 41(7):1113-1123. DOI: 10.1016/j.freeradbiomed.2006.06.016.
[10] NEMERE I. The 1, 25D3-MARRS protein: Contribution to steroid stimulated calcium uptake in chicks and rats[J]. Steroids, 2005, 70(5/6/7): 455-457. DOI: 10.1016/j.steroids.2005.02.005.
[11] SANSONE P, BROMBERG J. Targeting the interleukin-6/jak/stat pathway in human malignancies[J]. Journal of Clinical Oncology, 2012, 30(9): 1005-1014. DOI: 10.1200/jco.2010.31.8907.
[12] CHUNG H, CHO H, PERRY C, et al. Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer[J]. Biomarkers, 2013, 18(7): 573-579. DOI: 10.3109/1354750x.2013.827742.
[13] RAMOS F S, SERINO L T R, CARVALHO C M S, et al. PDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancer[J]. Genetics and Molecular Research, 2015, 14(2): 6960-6967. DOI: 10.4238/2015.june.26.4.
